2001 FDA SCIENCE FORUM
SCIENTIFIC ACHIEVEMENT AWARDS

Congratulations are in order!

The 2001 FDA Scientific Achievement Award recipients, and the Sigma Xi Best Poster Award recipients, announced at the Scientific Achievement Awards ceremony on February 16, are as follows:

EXCELLENCE IN ANALYTICAL SCIENCE

Steven M. Musser, Ph.D. - CFSAN
For important and outstanding contributions to the mission of the FDA through development of analytical methods using mass spectrometry.

EXCELLENCE IN LABORATORY SCIENCE

S. Jill James, Ph.D. - NCTR
For exceptional performance in elucidating the role of gene-nutrient interactions in the development of birth defects and cancer.

EXCELLENCE IN REVIEW SCIENCE

Nationwide Evaluation of X-ray Trends (NEXT) Group -CDRH
Orhan H. Suleiman, Ph.D.
David C. Spelic, Ph.D.
Richard Kaczmarek, M.S.
Stanley H. Stern, Ph.D.
Albert E. Moyal, M.S.
Thomas Ray Fewell, M.S.
Robert J. Jennings, Ph.D.
Robert M. Gagne, Ph.D.
Frank Cerra, M.S.,
Elizabeth V. Rodgers

For the Nationwide Evaluation of X-ray Trends (NEXT) public health survey program which measures the radiation levels and trends for United States diagnostic x-ray examinations.

OUTSTANDING INTERCENTER SCIENTIFIC COLLABORATION

Emanuel Petricoin, Ph.D. - CBER
*Frank Sistare, Ph.D. - CDER For the development of a rapid proteomic-based platform for toxicity screening using heuristic cluster analysis of SELDI protein biomarkers.

2001 Center/ORA Winners

Excellence in Analytical Science

Keya Sen, Ph.D.
CBER For development and optimization of a sensitive, specific and rapid method to detect small numbers of bacteria potentially contaminating blood and blood components.

Sergey V. Beiden, Ph.D.
Robert F. Wagner, Ph.D.
Gregory Campbell, Ph.D.
CDRH For the development of multrivariate models and software for the assessment of diagnostic tests, imaging, and computer-aided diagnosis in the presence of multiple random effects.

Steven M. Musser, Ph.D.
CFSAN For important and outstanding contributions to the mission of the FDA through development of analytical methods using mass spectrometry.

Dwight Miller, Ph.D.
Jon C. Wilkes, Ph.D.
NCTR For the development of inexpensive, mass-produced technologies in various forms providing consumers, wholesalers, and inspectors a means to estimate seafood freshness.

George M. Ware
ORA For his outstanding contribution in method development for natural toxins and other areas of significance to accomplish FDA’s mission.

Excellence in Laboratory Science

Emily Shacter, Ph.D.
CBER For studies elucidating how oxidation affects structure, function, and stability of therapeutic proteins and cellular substrates, leading to improved product safety and efficacy.

Ilko K. Ilev, Ph.D.
CDRH For outstanding fundamental research contributions in the technologies of medical fiber lasers, optical fiber delivery systems, biomedical sensor devices, and medical optical imaging systems.

Joseph E. LeClerc, Ph.D.
CFSAN For contributions in identifying sources of genetic variability in bacterial pathogens and revealing how promiscuous recombination and mutation may act in concert to accelerate the emergence of new traits in pathogen populations.

CVM
Patrick F. McDermott, Ph.D.
Renate Reimschuessel, V.M.D., Ph.D.
Shabbir Simjee, Ph.D. David D. Wagner, Ph.D.
Robert D. Walker
David G. White, Ph.D.
Shaohua Zhao, D.V.M.
For exemplary performance in addressing the microbiological safety of animal derived food.

S. Jill James, Ph.D.
NCTR For exceptional performance in elucidating the role of gene-nutrient interactions in the development of birth defects and cancer.

S. Frank Platek, M.S.
Nicola Ranieri
John B. Crowe
ORA For investigation and characterization of puncture holes in food and pharmaceutical containers, providing immediate information concerning the nature of consumer complaints in product tampering cases.

Excellence in Review Science

CDRH Nationwide Evaluation of X-ray Trends Group:
Orhan H. Suleiman, Ph.D.
David C. Spelic, Ph.D.
Richard Kaezmarek, M.S.
Stanley H. Stern, Ph.D.
Albert E. Moyal, M.S.
Thomas Ray Fewell, M.S.
Robert J. Jennings, Ph.D.
Robert M. Gagne, Ph.D.
Frank Cerra, M.S.
Elizabeth V. Rodgers
For the Nationwide Evaluation of X-ray Trends (NEXT) public health survey program which measures the radiation levels and trends for United States diagnostic x-ray examinations.

Michaela Alewynse, Ph.D.
CVM For excellence in the scientific review of the utility and safety of fermentation products and other microbial derivatives used in animal feed and feed ingredients.

James J. Chen, Ph.D.
NCTR For his outstanding contribution to review science in developing innovative statistical methods and providing creative solutions to statistical problems of regulatory significance.

Nominees for Outstanding Intercenter Scientific Collaboration

Filth Strategy Development Group:
Patricia Valdes Biles, CFSAN
Stanley M. Cichowicz, CFSAN John S. Gecan, CFSAN
Sherry A. Knight, ORA
Alan R. Olsen, CFSAN
Howard G. Semey, ORA
Thomas H. Sidebottom, ORA
George C. Ziobro, Ph.D., CFSAN
Outstanding intercenter scientific collaboration in developing a regulatory strategy with national and international applications that resolved health and safety issues regarding filth and extraneous materials.

DES Analytical Methology Team:
Pak-Sin Chu, Ph.D., CVM,
John M. Strong, Ph.D., CDER
Robert J. Parker, Ph.D., CDER
For the evaluation and improvement of an ultra-trace method of analysis of the synthetic hormone, diethylstilbestrol, in meat.

CVM/NCTR Antimicrobial Resistance Collaborative Research Team:
Roger A. Jones, Ph.D., CVM
Jeffrey M. Gilbert, Ph.D., CVM
Mohammed S. Nawaz, Ph.D., NCTR
Saeed Khan, Ph.D., NCTR
Ashraf A. Khan, Ph.D., CVM
Robert D. Wagner, Ph.D., CVM
For outstanding contribution to the understanding of emergence and dissemination of antimicrobial resistance in environmental settings and for the detection thereof in competitive exclusion cultures.

Emanuel Petricoin, Ph.D., CBER
*Frank Sistare, Ph.D., CDER For the development of a rapid proteomic-based platform for toxicity screening using heuristic cluster analysis of SELDI protein biomarkers

* Commissioned Corps

POSTER AWARDS FOR THE 2001 FDA SCIENCE FORUM
Presented by the FDA Chapter of Sigma Xi

First Place

First Place Poster - 2001 FDA Science Forum

Board E12

Egg Safety: Flies That Carry Salmonella Enteritidis
Alan R. Olsen and Thomas S. Hammack. CFSAN, FDA, Washington, DC 20204.
Second Place

Second Place Poster - 2001 FDA Science Forum

Board M01a

Analysis of Flour and Food Samples for Genetically Modified Corn
Keith A. Lampel, Dan D. Levy, Samir K. Assar, Laurenda Carter, Paul K. South and Palmer A. Orlandi, CFSAN, FDA, Washington DC 20204
Third Place

Third Place Poster - 2001 FDA Science Forum

Board A01

Expression of prion protein on endothelial cells.
K. Holada, J. Simak, F. D`Agnillo, J.G. Vostal
Honorable Mention

Honorable Mention Poster - 2001 FDA Science Forum

Board E13

Food Safety Program for 5th & 6th graders in Novosibirsk, Russia
L.B. Koopman, CFSAN, FDA, Washington DC 20204
Honorable Mention

Honorable Mention Poster - 2001 FDA Science Forum

Board Q01

Medication Safety for Limited English Proficiency Asian and Pacific Islander Americans
Laurel Eu, Los Angeles District Office, FDA, Irvine, California 92612
Honorable Mention

Honorable Mention Poster - 2001 FDA Science Forum

Board R01

A Unique Animal Model for the Study of Drug Transfer from Mother to Offspring During the Perinatal Period.
P. L. Chamberlain, J. Peggins and J. von Bredow, CVM, FDA, Laurel, MD
Honorable Mention

Honorable Mention Poster - 2001 FDA Science Forum

Board R19

The Effects of St. John's Wort on Pharmacokinetics of Fexofenadine
Zaiqi Wang1, MD, Mitchell A. Hamman11, PhD, D. Craig Brater1, MD, Shiew-Mei Huang2, PhD, Lawrence J Lesko2, Ph.D., Stephen D. Hall1, PhD*, 1Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, 2Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD
Honorable Mention

Honorable Mention Poster - 2001 FDA Science Forum

Board T10

Accumulation of Octamethylcyclotetrasiloxane (D4) in Women Exposed to Silicone Products.
H.-M.D. Luu and J.C. Hutter, Chemistry Branch, DMMS, CDRH, FDA, Rockville MD 20852
Leveraging Activites

Group Award for Leveraging Activities - 2001 FDA Science Forum

Board B03

STUDIES ON PARAMETERS OF UV RESPONSE IN HUMAN SKIN: A PROGRESS REPORT
J.Z. Beer1, H.F. Bushar1, D.N. Busick1, D.J. Chwirut1, W.H. Cyr1, M.N. Ediger1, N.T. Lao1, L.S. Matchette1, S.A. Miller1, H. Lopez1, S. Weininger1, B.Z. Zmudzka1, E. Toombs2, H. Jorgensen3, K.S. Korossy4, V.J. Hearing5, N. Kobayashi5, T. Tadokoro5, J.C. van der Leun6, E. Lenderink7, 1CDRH, FDA, Rockville MD, 2CFSAN, FDA, Washington DC, 3Washington Hospital Center, Washington, DC, 4Kensington, MD, 5NCI, NIH, Bethesda MD, 6Utrecht University, Utrecht, The Netherlands, 7Philips Research, Eindhoven, The Netherlands.
Leveraging Activites

Group Award for Leveraging Activities - 2001 FDA Science Forum

Board B04

EXAMINATION OF DNA DAMAGE INDUCED BY ULTRAVIOLET IRRADIATION OF HUMAN SKIN WITHIN RACIAL/ETHNIC GROUPS
T. Tadokoro1, N. Kobayashi1, J.Z. Beer2, B.Z. Zmudzka2, K.S. Korossy2, V.J. Hearing. 1NCI/NIH, Bethesda MD; 2CDRH, Rockville MD
Leveraging Activites

Group Award for Leveraging Activities - 2001 FDA Science Forum

Board B05

UV-INDUCED ERYTHEMA VS. SKIN TYPE AND RACE/ETHNICITY: VISUAL AND INSTRUMENTAL EXPLORATIONS.
B.Z. Zmudzka1, N.T. Lao1, S.A. Miller1, J.C. van der Leun2, J.Z. Beer1, 1Food and Drug Administration, Rockville, MD 20852, U.S.A, 2University of Utrecht, Utrecht, The Netherlands
Leveraging Activites

Group Award for Leveraging Activities - 2001 FDA Science Forum

Board C03

The New FDA Magnetic Resonance Imaging (MRI) Facility
The FDA MRI Interest Group, Jan Johannessen, Group CoordinatorCDER: Pat Faustino, Joe Hanig, David Lester, Robbe Lyon, Jim WitterCDRH: Larry Grossman, John Karanian, Kyle Myers, Bill Pritchard, Terry Woods, Loren ZarembaCFSAN: Sandra Bell, Fred Fry, Darcy Hanes, Susan Harper, Fred Hines, Jan Johannessen, Gene Mazzola, Kevin Reed, Ben TallCVM: Wende Jones. Renate Reimschuessel, Stan Serfling, Linda Wilmont, Tania WoernerNCFST: Melvin PascallNCTR: Merle Paul, Jon Popke, Andy Scallet,Bill SlikkerOFACS:Tom Jacobs
Leveraging Activites

Group Award for Leveraging Activities - 2001 FDA Science Forum

Board D09a

Human Illness from Seafood Toxins: Outbreak Investigation
S. Hall1, P.P. Eilers1, S.M. Conrad1, S.M. Musser1, M. Poli2, 1CFSAN, FDA, Washington DC 20204, 2USAMRIID, Frederick MD 21702
Leveraging Activites

Group Award for Leveraging Activities - 2001 FDA Science Forum

Board E11

SEAPORT: Grassroots Leveraging in Support of the FDA Mission
S.M. Conrad1, P.P. Eilers1, S. Hall1, G. Langlois2, P. Anderson3, C. Dolan4, J.M. Hickey5, M. Shute6, 1CFSAN, FDA, Washington DC 20204, 2CA Dept. Health Services, Berkeley CA 94704, 3ME Sea Grant Program, Univ. ME, Orono ME 04469, 4Univ. NH Cooperative Ext., Durham NH 08824, 5MA Div. Marine Fisheries, Pocasett MA 02559, 6CT Dept. Agriculture, Milford CT 06460
Leveraging Activites

Group Award for Leveraging Activities - 2001 FDA Science Forum

Board T02

Seafood Toxins: Characterizing the Source and Nature of Toxins Accumulated by Shellfish
P.P. Eilers1, S.M. Conrad1, S. Hall1, G. Langlois2, J. Matweyou3, G. Plumley3, 1CFSAN, FDA, Washington DC 20204, 2CA Dept. Health Services, Berkeley CA 94704, 3Univ. of Alaska, Fairbanks AK 99701

2001 FDA Science Forum | FDA Chapter, Sigma Xi | CFSAN | FDA
Last updated on 2001-MAR-01 by frf